You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotoxins

Showing 26 - 50 of 61
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain and CNS Tumors Trial in Orange, Charleston (transferrin-CRM107)

Unknown status
  • Brain and Central Nervous System Tumors
  • transferrin-CRM107
  • Orange, California
  • +1 more
May 14, 2018

Colorectal Tumors Trial in Oslo (MOC31PE Immunotoxin)

Completed
  • Colorectal Neoplasms
  • MOC31PE Immunotoxin
  • Oslo, Norway
    Oslo University Hospital- The Norwegian Radium Hospital
May 24, 2017

GVHD, MDS, Leukemia Trial run by the NHLBI (RFT5-SMPT-dgA, Isolex system)

Completed
Has Results
  • Graft vs Host Disease
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2016

Biomarkers in Samples From Young Patients With Neuroblastoma

Completed
  • Neuroblastoma
  • polymerase chain reaction
  • +5 more
  • (no location specified)
Apr 14, 2016

Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial run by the NCI (SS1(dsFv)-PE38 immunotoxin)

Completed
  • Cervical Cancer
  • +7 more
  • SS1(dsFv)-PE38 immunotoxin
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015

Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial in Bethesda, Winston-Salem (SS1(dsFv)-PE38 immunotoxin)

Completed
  • Cervical Cancer
  • +7 more
  • SS1(dsFv)-PE38 immunotoxin
  • Bethesda, Maryland
  • +1 more
Apr 29, 2015

Leukemia, Lymphoma Trial run by the NCI (LMB-2 immunotoxin)

Completed
  • Leukemia
  • Lymphoma
  • LMB-2 immunotoxin
  • Bethesda, Maryland
  • +1 more
Apr 28, 2015

Hairy Cell Leukemia Trial run by the NCI (BL22 (CAT-3888))

Terminated
Has Results
  • Hairy Cell Leukemia
  • BL22 (CAT-3888)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 7, 2015

Bladder Cancer, Breast Cancer, Colorectal Cancer Trial run by the NCI (LMB-9 immunotoxin)

Completed
  • Bladder Cancer
  • +6 more
  • LMB-9 immunotoxin
  • Bethesda, Maryland
    Medicine Branch
Apr 28, 2015

Leukemia Trial run by the NCI (BL22 immunotoxin)

Completed
  • Leukemia
  • BL22 immunotoxin
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 28, 2015

Leukemia, Lymphoma Trial in United States (LMB-2 immunotoxin)

Completed
  • Leukemia
  • Lymphoma
  • LMB-2 immunotoxin
  • Atlanta, Georgia
  • +4 more
Apr 29, 2015

Leukemia, Lymphoma Trial run by the NCI (BL22 immunotoxin, antibody therapy, biological response modifier therapy)

Withdrawn
  • Leukemia
  • Lymphoma
  • BL22 immunotoxin
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 27, 2015

Tumors Trial run by the (SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin)

Withdrawn
  • Neoplasms
  • SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin
  • Bethesda, Maryland
    NCI/NIH
Nov 13, 2014

HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent NSCLC Trial in Seattle (drug, biological, other)

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • ex vivo-expanded HER2-specific T cells
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 7, 2014

Colorectal Cancer, Esophageal Cancer, Gastric Cancer Trial in Freiburg (LMB-9 immunotoxin)

Unknown status
  • Colorectal Cancer
  • +3 more
  • LMB-9 immunotoxin
  • Freiburg, Germany
    Universitaetsklinikum Freiburg
Dec 18, 2013

Brain and CNS Tumors Trial in United States (biological, drug, procedure)

Completed
  • Brain and Central Nervous System Tumors
  • cintredekin besudotox
  • +2 more
  • Birmingham, Alabama
  • +10 more
Jun 20, 2013

Brain and CNS Tumors Trial in New York (cintredekin besudotox, adjuvant therapy, conventional surgery)

Completed
  • Brain and Central Nervous System Tumors
  • cintredekin besudotox
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 25, 2013

Brain and CNS Tumors Trial in Durham, Philadelphia (LMB-7 immunotoxin)

Completed
  • Brain and Central Nervous System Tumors
  • LMB-7 immunotoxin
  • Durham, North Carolina
  • +1 more
Feb 15, 2013

Melanoma (Skin), Non-melanomatous Skin Cancer Trial run by the CC (LMB-2 immunotoxin, MART-1 antigen, gp100 antigen)

Completed
  • Melanoma (Skin)
  • Non-melanomatous Skin Cancer
  • LMB-2 immunotoxin
  • +3 more
  • Bethesda, Maryland
  • +1 more
Jun 12, 2012

Recurrent Glioblastoma Multiforme Trial (TP-38, TP38)

Completed
  • Recurrent Glioblastoma Multiforme
  • (no location specified)
Jan 18, 2012

CHRONIC LYMPHOCYTIC B-LEUKEMIA Trial (IL-2 secreting and hCL4OL-expressing autologous B-CLL cells, IL-2, CD40L)

Withdrawn
  • CHRONIC LYMPHOCYTIC B-LEUKEMIA
  • IL-2 secreting and hCL4OL-expressing autologous B-CLL cells
  • +4 more
  • (no location specified)
May 18, 2012

Lymphoma Trial run by the CC (biological, drug, other)

Withdrawn
  • Lymphoma
  • LMB-2 immunotoxin
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012

Carcinoma Trial in Oslo (MOC31-PE)

Completed
  • Carcinoma
  • Oslo, Norway
    The Norwegian Radium Hospital, Department of Clinical Cancer Res
May 3, 2012

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in Seattle (biological, procedure, other, genetic)

Terminated
  • Recurrent Melanoma
  • +2 more
  • therapeutic autologous lymphocytes
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Dec 2, 2011

Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Durham (IL13-PE38QQR, targeted fusion protein

Completed
  • Malignant Glioma
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Jun 2, 2011